Feasibility and ethical issues: experiences and concerns of healthcare workers regarding a new RSV prophylaxis programme in Nunavik, Quebec

Background: The respiratory syncytial virus (RSV) is a major cause of hospitalisation in young Inuit children. Prophylaxis with palivizumab is routinely recommended for premature infants and those with severe pulmonary or cardiac diseases. In the fall 2016, the Quebec Ministry of Health expanded the...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Armelle Lorcy, Rodica Gilca, Eve Dubé, Marie Rochette, Gaston De Serres
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Taylor & Francis Group 2020-01-01
Ráidu:	International Journal of Circumpolar Health
Fáttát:	respiratory syncytial virus palivizumab health-care workers experiences opinions inuit health services
Liŋkkat:	http://dx.doi.org/10.1080/22423982.2020.1742564
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!